Agilent Signs Software Co-Marketing Agreement with ACD/Labs | GenomeWeb
NEW YORK (GenomeWeb News) – Agilent Technologies and Advanced Chemistry Development said today that they have agreed to co-market ACD/Labs’ AutoChrom method-development software with Agilent’s ChemStation instrument-control software for its HPLC, Rapid Resolution LC, and LC/MS systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.